LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Does Depression Increase Opioid Use Among OA Patients?
Large Joints and Extremities

Does Depression Increase Opioid Use Among OA Patients?

May 8, 2019 2 min read Premium comments

Advertisement

Does Depression Increase Opioid Use Among OA Patients?
Source: Wikimedia Commons and Judithcarlin
Secondary#kneeosteoarthritis#depression#analgesic

To examine the role of mental health and social support in the use of different pain medications among knee osteoarthritis (OA) patients, a team of researchers examined 360 individuals, categorizing them based on use of these oral medications: opioids (with/without other oral analgesic treatments), non-opioid analgesics, and no oral analgesic treatment.

The study, “Social & psychological factors associated with oral analgesic use in knee osteoarthritis management,” was published in the February 1, 2019 edition of Osteoarthritis and Cartilage.

Co-author Ernest R. Vina, M.D., M.S., assistant professor of medicine in the University of Arizona College of Medicine, explained the foundation for the study to OTW, “In the ambulatory setting, we have found that patients’ social and psychological health tend to affect whether or not they will use certain medications. For example, those with low level of social support tend to rely more on prescription than over-the-counter pain medications. Those with mental health challenges, such as depression or anxiety, are also more likely to use opioid medicines.”

“The majority of patients with knee OA in the study were not using opioid medications. Most were using acetaminophen and/or anti-inflammatory agents. Opioid analgesic users, compared to others, were more likely to have moderate-to-severe depressive symptoms and lower social support. A higher level of depression was also associated with opioid vs. no oral analgesic use, independent of various patient sociodemographic and clinical (like OA disease severity and body mass index) characteristics.”

Specifically, of the patients who were enrolled in the study, 30.6% (n = 110) reported taking opioid analgesics for OA, 54.2% (n = 195) reported non-opioid use, and 15.3% (n = 55) reported no oral analgesic use. The investigators also recorded that patients who self-reported opioid use also reported lower mean social support scores and were more likely to have moderate-severe depressive symptoms.

Dr. Vina, also with the University of Arizona Arthritis Center, summarized the conclusions from the study to OTW, “Physicians and surgeons should consider screening OA patients for mood disorders, such as depression. Identification of such psychological disorders could lead to an early implementation of a management plan to improve the outcomes of patients with OA. Prescribing an anti-depressant therapy or referring a patient to a mental health specialist in tandem with providing a medication for OA may be appropriate in certain patients.”

“There is a growing opioid epidemic in the U.S. Knee OA patients with severe depression symptoms and those with low level of social support are more likely to report using opioid analgesics for OA treatment.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy